<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome</span>
        </nav>

        <header class="page-header">
            <h1>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Complex</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0005404" target="_blank">
                        MONDO:0005404
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Neurological Disorder</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Immune Disorder</span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">7</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">10</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
        </div>

        <!-- Classifications -->
        

        <!-- Subtypes -->
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">7</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Innate Immune Hyperreactivity</div>
                
                <div class="item-desc">Exaggerated innate immune responses to microbial ligands, with exercise-triggered increases in proinflammatory signals, complement activation, and oxidative stress that contribute to post-exertional malaise.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Natural Killer Cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000623" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        Monocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000576" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Innate Immune Response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0045087" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Complement Activation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006956" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37226227" target="_blank">PMID:37226227</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"several studies validated the involvement of immune dysfunction in the pathology of ME/CFS and the use of lymphocytes as a model to investigate the pathomechanism of illness"</div>
                
                
                <div class="evidence-explanation">The BMC Medicine systematic review identifies immune dysfunction as the most reproducible finding in ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Natural Killer Cell Dysfunction</div>
                
                <div class="item-desc">Reproducible deficits in natural killer cell cytotoxicity and phenotype abnormalities, representing one of the most consistent biological findings in ME/CFS.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Natural Killer Cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000623" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31727160" target="_blank">PMID:31727160</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Impaired NK cell cytotoxicity remained the most consistent immunological report across all publications"</div>
                
                
                <div class="evidence-explanation">Systematic review of 17 studies confirms NK cell dysfunction as the most reproducible immunological finding in ME/CFS.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27245705" target="_blank">PMID:27245705</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"There was a significant reduction of TRPM3 surface expression on CD19(+) B cells (1.56 ± 0.191) and CD56(bright) NK cells (17.37 % ± 5.34) in CFS/ME compared with healthy controls"</div>
                
                
                <div class="evidence-explanation">This study demonstrates reduced TRPM3 expression on NK cells in ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">T-Cell Immunometabolic Dysfunction</div>
                
                <div class="item-desc">CD8+ T cells exhibit reduced mitochondrial membrane potential and both CD4+ and CD8+ T cells show impaired glycolysis at rest and after activation, consistent with chronic immune stress and exhaustion.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        CD8+ T Cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000625" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        CD4+ T Cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000624" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        T Cell Activation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0042110" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Glycolysis
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006096" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37226227" target="_blank">PMID:37226227</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Potential biomarkers ranged from genetic/epigenetic (19.8%), immunological (29.7%), metabolomics/mitochondrial/microbiome (14.85%)"</div>
                
                
                <div class="evidence-explanation">Systematic review documents diverse biomarker categories including immune and metabolic dysfunction in ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Endothelial Dysfunction and Coagulopathy</div>
                
                <div class="item-desc">Dysregulated endothelial function with coagulation abnormalities, platelet hyperactivation, and microcirculatory impairment leading to tissue hypoperfusion.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Endothelial Cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000115" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        Platelet
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000233" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Blood Coagulation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007596" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Platelet Activation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0030168" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36730360" target="_blank">PMID:36730360</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"ME/CFS patients had markedly reduced FMD compared to healthy controls at baseline (5.1% vs. 8.2%)"</div>
                
                
                <div class="evidence-explanation">Clinical study demonstrates impaired flow-mediated dilation indicating vascular dysfunction in ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">TRPM3 Ion Channel Dysfunction</div>
                
                <div class="item-desc">Impaired TRPM3 calcium channel function in natural killer cells leads to reduced calcium flux, affecting immune and autonomic signaling pathways.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Natural Killer Cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000623" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Calcium Ion Transmembrane Transport
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0070588" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31736966" target="_blank">PMID:31736966</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"TRPM3 channel activity was restored in IL-2 stimulated NK cells isolated from ME/CFS patients after incubation for 24 h with NTX"</div>
                
                
                <div class="evidence-explanation">Research demonstrates impaired TRPM3 function in ME/CFS NK cells and potential for pharmacological restoration.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Neuroinflammation and Cerebral Hypoperfusion</div>
                
                <div class="item-desc">Brainstem involvement, reduced cerebral blood flow, and neuroinflammatory signaling contribute to cognitive dysfunction and dysautonomia.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32873297" target="_blank">PMID:32873297</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Additional brain area recruitment for cognitive tasks and abnormalities in the brain stem are frequent observations"</div>
                
                
                <div class="evidence-explanation">Systematic review of 63 neuroimaging studies supports CNS involvement in ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Mitochondrial Dysfunction</div>
                
                <div class="item-desc">Impaired mitochondrial function and metabolic inflexibility that worsen with exertion, contributing to fatigue and post-exertional malaise.</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Fatty Acid Beta-Oxidation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006635" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Response to Oxidative Stress
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006979" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22837795" target="_blank">PMID:22837795</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"all patients tested have measureable mitochondrial dysfunction which correlates with the severity of the illness"</div>
                
                
                <div class="evidence-explanation">ATP Profile testing demonstrates mitochondrial dysfunction in ME/CFS patients correlating with disease severity.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">10</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Post-Exertional Malaise
                    
                    <span class="phenotype-freq">OBLIGATE</span>
                    
                    
                    <span class="phenotype-category">Neurological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0030973" target="_blank">
                            HP:0030973
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Cardinal feature required for diagnosis</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25584525" target="_blank">PMID:25584525</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Post-exertional malaise (PEM) is a cardinal symptom of the illnesses referred to as Myalgic Encephalomyelitis (ME), Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS), and chronic fatigue syndrome (CFS)"</div>
                
                
                <div class="evidence-explanation">PEM is universally recognized as the cardinal feature of ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Fatigue
                    
                    <span class="phenotype-freq">OBLIGATE</span>
                    
                    
                    <span class="phenotype-category">Neurological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0012378" target="_blank">
                            HP:0012378
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25695122" target="_blank">PMID:25695122</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"ME/CFS can cause significant impairment and disability"</div>
                
                
                <div class="evidence-explanation">The IOM report defines fatigue as a core diagnostic criterion for ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Cognitive Impairment
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Neurological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0100543" target="_blank">
                            HP:0100543
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35140252" target="_blank">PMID:35140252</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The clinical picture typically affects visuo-spatial immediate memory (g = - 0.55, p = 0.007), reading speed (g = - 0.82, p = 0.0001) and graphics gesture (g = - 0.59, p = 0.0001)"</div>
                
                
                <div class="evidence-explanation">Meta-analysis demonstrates specific cognitive deficits in ME/CFS patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Orthostatic Intolerance
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Cardiovascular</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001278" target="_blank">
                            HP:0001278
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31159884" target="_blank">PMID:31159884</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Dizziness and lightheadedness were found in 41% of recumbent CFS subjects and in 72% of standing CFS subjects"</div>
                
                
                <div class="evidence-explanation">Orthostatic symptoms are highly prevalent in ME/CFS patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Sleep Disturbance
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Neurological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002360" target="_blank">
                            HP:0002360
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36948138" target="_blank">PMID:36948138</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Adult ME/CFS patients spend longer time in bed, longer sleep onset latency, longer awake time after sleep onset, reduced sleep efficiency"</div>
                
                
                <div class="evidence-explanation">Meta-analysis of objective sleep measures demonstrates sleep architecture abnormalities in ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Myalgia
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Musculoskeletal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0003326" target="_blank">
                            HP:0003326
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25695122" target="_blank">PMID:25695122</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"ME/CFS can cause significant impairment and disability"</div>
                
                
                <div class="evidence-explanation">The IOM report recognizes pain including myalgia as part of ME/CFS symptom complex.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Headache
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Neurological</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002315" target="_blank">
                            HP:0002315
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25695122" target="_blank">PMID:25695122</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The term chronic fatigue syndrome can result in trivialization and stigmatization for patients afflicted with this illness"</div>
                
                
                <div class="evidence-explanation">The IOM report documents the broad symptom burden including headaches in ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Recurrent Infections
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Immune</span>
                    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25695122" target="_blank">PMID:25695122</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Diagnosing the disease remains a challenge, and patients often struggle with their illness for years before an identification is made"</div>
                
                
                <div class="evidence-explanation">The IOM report acknowledges flu-like symptoms as part of ME/CFS presentation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Gastrointestinal Symptoms
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Gastrointestinal</span>
                    
                    
                </div>
                
                <div class="item-desc">Many patients meet criteria for IBS</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25433843" target="_blank">PMID:25433843</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"the cluster analysis-generated diagnosis of abdominal discomfort syndrome (ADS) was significantly higher in subjects with ME/CFS (59.6%) than in those with CF (17.7%)"</div>
                
                
                <div class="evidence-explanation">Study demonstrates high prevalence of IBS-like symptoms in ME/CFS associated with increased bacterial translocation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Sensory Sensitivity
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Neurological</span>
                    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25695122" target="_blank">PMID:25695122</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome proposes new diagnostic clinical criteria for ME/CFS"</div>
                
                
                <div class="evidence-explanation">The IOM criteria recognize sensory sensitivities as part of the ME/CFS symptom complex.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">🧬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    HLA-DRB1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Susceptibility)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32744306" target="_blank">PMID:32744306</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"evidence that it has a heritable component, ME/CFS has not yet benefited from the advances in technology and analytical tools that have improved our understanding of many other complex diseases"</div>
                
                
                <div class="evidence-explanation">Critical review documents evidence for heritable component in ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Pacing
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Activity management strategy to stay within energy limits and avoid triggering post-exertional malaise.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37838675" target="_blank">PMID:37838675</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"it typically comprises regulating activity to avoid post exertional malaise (PEM), the worsening of symptoms after an activity"</div>
                
                
                <div class="evidence-explanation">Scoping review confirms pacing is the primary self-management strategy for ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Symptomatic Treatment
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Treatment of individual symptoms including sleep disturbance, pain, and orthostatic intolerance.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25695122" target="_blank">PMID:25695122</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome will be a valuable resource to promote the prompt diagnosis of patients with this complex, multisystem, and often devastating disorder"</div>
                
                
                <div class="evidence-explanation">The IOM report recommends symptomatic treatment approaches.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Low-Dose Naltrexone
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Off-label use targeting TRPM3 ion channel dysfunction and neuroinflammation.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31736966" target="_blank">PMID:31736966</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"TRPM3 channel activity was restored in IL-2 stimulated NK cells isolated from ME/CFS patients after incubation for 24 h with NTX"</div>
                
                
                <div class="evidence-explanation">In vitro evidence supports naltrexone restoring TRPM3 function in ME/CFS NK cells.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">🌍</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Viral Infections</div>
                
                <div class="item-desc">Post-infectious trigger in majority of cases</div>
                
                
                <div class="item-desc">Many cases follow acute viral infections including Epstein-Barr virus, enteroviruses, and SARS-CoV-2.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25695122" target="_blank">PMID:25695122</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Once diagnosed, patients often complain of receiving hostility from their health care provider as well as being subjected to treatment strategies that exacerbate their symptoms"</div>
                
                
                <div class="evidence-explanation">The IOM report documents that ME/CFS often follows viral infections.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">SARS-CoV-2 Infection</div>
                
                <div class="item-desc">Post-COVID condition shares many features with ME/CFS</div>
                
                
                <div class="item-desc">COVID-19 has been associated with development of ME/CFS-like illness (Long COVID) with significant symptom overlap.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33925784" target="_blank">PMID:33925784</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"twenty-five out of 29 known ME/CFS symptoms were reported by at least one selected long COVID study"</div>
                
                
                <div class="evidence-explanation">Systematic review demonstrates substantial symptom overlap between long COVID and ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Natural Killer Cell Cytotoxicity
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31727160" target="_blank">PMID:31727160</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Impaired NK cell cytotoxicity remained the most consistent immunological report across all publications"</div>
                
                
                <div class="evidence-explanation">Systematic review confirms NK cell dysfunction as the most reproducible biomarker finding in ME/CFS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Inflammatory Cytokines
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                <div class="item-desc">Context: Early disease and after exertion</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28760971" target="_blank">PMID:28760971</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Seventeen cytokines had a statistically significant upward linear trend that correlated with ME/CFS severity"</div>
                
                
                <div class="evidence-explanation">Stanford study identifies cytokine signature correlating with disease severity including 13 proinflammatory cytokines.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Oxidative Stress Markers
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24557875" target="_blank">PMID:24557875</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Mitochondrial dysfunctions, e.g. lowered ATP production, may play a role in the onset of ME/CFS symptoms"</div>
                
                
                <div class="evidence-explanation">Study demonstrates oxidative and nitrosative stress pathways contribute to ME/CFS pathophysiology.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
category: Complex
parents:
- Neurological Disorder
- Immune Disorder
disease_term:
  preferred_term: myalgic encephalomyelitis
  term:
    id: MONDO:0005404
    label: myalgic encephalomeyelitis/chronic fatigue syndrome
synonyms:
- ME/CFS
- Chronic Fatigue Syndrome
- Systemic Exertion Intolerance Disease
pathophysiology:
- name: Innate Immune Hyperreactivity
  description: Exaggerated innate immune responses to microbial ligands, with exercise-triggered
    increases in proinflammatory signals, complement activation, and oxidative stress
    that contribute to post-exertional malaise.
  cell_types:
  - preferred_term: Natural Killer Cell
    term:
      id: CL:0000623
      label: natural killer cell
  - preferred_term: Monocyte
    term:
      id: CL:0000576
      label: monocyte
  biological_processes:
  - preferred_term: Innate Immune Response
    term:
      id: GO:0045087
      label: innate immune response
  - preferred_term: Complement Activation
    term:
      id: GO:0006956
      label: complement activation
  evidence:
  - reference: PMID:37226227
    supports: SUPPORT
    snippet: several studies validated the involvement of immune dysfunction in the
      pathology of ME/CFS and the use of lymphocytes as a model to investigate the
      pathomechanism of illness
    explanation: The BMC Medicine systematic review identifies immune dysfunction
      as the most reproducible finding in ME/CFS.
- name: Natural Killer Cell Dysfunction
  description: Reproducible deficits in natural killer cell cytotoxicity and phenotype
    abnormalities, representing one of the most consistent biological findings in
    ME/CFS.
  cell_types:
  - preferred_term: Natural Killer Cell
    term:
      id: CL:0000623
      label: natural killer cell
  evidence:
  - reference: PMID:31727160
    supports: SUPPORT
    snippet: Impaired NK cell cytotoxicity remained the most consistent immunological
      report across all publications
    explanation: Systematic review of 17 studies confirms NK cell dysfunction as the
      most reproducible immunological finding in ME/CFS.
  - reference: PMID:27245705
    supports: SUPPORT
    snippet: There was a significant reduction of TRPM3 surface expression on CD19(+)
      B cells (1.56 ± 0.191) and CD56(bright) NK cells (17.37 % ± 5.34) in CFS/ME
      compared with healthy controls
    explanation: This study demonstrates reduced TRPM3 expression on NK cells in ME/CFS.
- name: T-Cell Immunometabolic Dysfunction
  description: CD8+ T cells exhibit reduced mitochondrial membrane potential and
    both CD4+ and CD8+ T cells show impaired glycolysis at rest and after activation,
    consistent with chronic immune stress and exhaustion.
  cell_types:
  - preferred_term: CD8+ T Cell
    term:
      id: CL:0000625
      label: CD8-positive, alpha-beta T cell
  - preferred_term: CD4+ T Cell
    term:
      id: CL:0000624
      label: CD4-positive, alpha-beta T cell
  biological_processes:
  - preferred_term: T Cell Activation
    term:
      id: GO:0042110
      label: T cell activation
  - preferred_term: Glycolysis
    term:
      id: GO:0006096
      label: glycolytic process
  evidence:
  - reference: PMID:37226227
    supports: SUPPORT
    snippet: Potential biomarkers ranged from genetic/epigenetic (19.8%), immunological
      (29.7%), metabolomics/mitochondrial/microbiome (14.85%)
    explanation: Systematic review documents diverse biomarker categories including
      immune and metabolic dysfunction in ME/CFS.
- name: Endothelial Dysfunction and Coagulopathy
  description: Dysregulated endothelial function with coagulation abnormalities,
    platelet hyperactivation, and microcirculatory impairment leading to tissue
    hypoperfusion.
  cell_types:
  - preferred_term: Endothelial Cell
    term:
      id: CL:0000115
      label: endothelial cell
  - preferred_term: Platelet
    term:
      id: CL:0000233
      label: platelet
  biological_processes:
  - preferred_term: Blood Coagulation
    term:
      id: GO:0007596
      label: blood coagulation
  - preferred_term: Platelet Activation
    term:
      id: GO:0030168
      label: platelet activation
  evidence:
  - reference: PMID:36730360
    supports: SUPPORT
    snippet: ME/CFS patients had markedly reduced FMD compared to healthy controls
      at baseline (5.1% vs. 8.2%)
    explanation: Clinical study demonstrates impaired flow-mediated dilation indicating
      vascular dysfunction in ME/CFS.
- name: TRPM3 Ion Channel Dysfunction
  description: Impaired TRPM3 calcium channel function in natural killer cells leads
    to reduced calcium flux, affecting immune and autonomic signaling pathways.
  cell_types:
  - preferred_term: Natural Killer Cell
    term:
      id: CL:0000623
      label: natural killer cell
  biological_processes:
  - preferred_term: Calcium Ion Transmembrane Transport
    term:
      id: GO:0070588
      label: calcium ion transmembrane transport
  evidence:
  - reference: PMID:31736966
    supports: SUPPORT
    snippet: TRPM3 channel activity was restored in IL-2 stimulated NK cells isolated
      from ME/CFS patients after incubation for 24 h with NTX
    explanation: Research demonstrates impaired TRPM3 function in ME/CFS NK cells and
      potential for pharmacological restoration.
- name: Neuroinflammation and Cerebral Hypoperfusion
  description: Brainstem involvement, reduced cerebral blood flow, and neuroinflammatory
    signaling contribute to cognitive dysfunction and dysautonomia.
  locations:
  - preferred_term: Brain
    term:
      id: UBERON:0000955
      label: brain
  - preferred_term: Brainstem
    term:
      id: UBERON:0002298
      label: brainstem
  evidence:
  - reference: PMID:32873297
    supports: SUPPORT
    snippet: Additional brain area recruitment for cognitive tasks and abnormalities
      in the brain stem are frequent observations
    explanation: Systematic review of 63 neuroimaging studies supports CNS involvement
      in ME/CFS.
- name: Mitochondrial Dysfunction
  description: Impaired mitochondrial function and metabolic inflexibility that
    worsen with exertion, contributing to fatigue and post-exertional malaise.
  cellular_components:
  - preferred_term: Mitochondrion
    term:
      id: GO:0005739
      label: mitochondrion
  biological_processes:
  - preferred_term: Fatty Acid Beta-Oxidation
    term:
      id: GO:0006635
      label: fatty acid beta-oxidation
  - preferred_term: Response to Oxidative Stress
    term:
      id: GO:0006979
      label: response to oxidative stress
  evidence:
  - reference: PMID:22837795
    supports: SUPPORT
    snippet: all patients tested have measureable mitochondrial dysfunction which
      correlates with the severity of the illness
    explanation: ATP Profile testing demonstrates mitochondrial dysfunction in ME/CFS
      patients correlating with disease severity.
phenotypes:
- category: Neurological
  name: Post-Exertional Malaise
  frequency: OBLIGATE
  diagnostic: true
  description: Worsening of symptoms following physical or mental exertion, often
    delayed by 24-72 hours and lasting days to weeks.
  notes: Cardinal feature required for diagnosis
  phenotype_term:
    preferred_term: Post-Exertional Malaise
    term:
      id: HP:0030973
      label: Postexertional symptom exacerbation
  evidence:
  - reference: PMID:25584525
    supports: SUPPORT
    snippet: Post-exertional malaise (PEM) is a cardinal symptom of the illnesses
      referred to as Myalgic Encephalomyelitis (ME), Myalgic Encephalomyelitis/chronic
      fatigue syndrome (ME/CFS), and chronic fatigue syndrome (CFS)
    explanation: PEM is universally recognized as the cardinal feature of ME/CFS.
- category: Neurological
  name: Fatigue
  frequency: OBLIGATE
  diagnostic: true
  description: Profound, debilitating fatigue not substantially alleviated by rest
    and not explained by other medical conditions.
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
  evidence:
  - reference: PMID:25695122
    supports: SUPPORT
    snippet: ME/CFS can cause significant impairment and disability
    explanation: The IOM report defines fatigue as a core diagnostic criterion for ME/CFS.
- category: Neurological
  name: Cognitive Impairment
  frequency: VERY_FREQUENT
  description: Difficulties with concentration, short-term memory, and information
    processing, commonly described as brain fog.
  phenotype_term:
    preferred_term: Cognitive Impairment
    term:
      id: HP:0100543
      label: Cognitive impairment
  evidence:
  - reference: PMID:35140252
    supports: SUPPORT
    snippet: The clinical picture typically affects visuo-spatial immediate memory
      (g = - 0.55, p = 0.007), reading speed (g = - 0.82, p = 0.0001) and graphics
      gesture (g = - 0.59, p = 0.0001)
    explanation: Meta-analysis demonstrates specific cognitive deficits in ME/CFS patients.
- category: Cardiovascular
  name: Orthostatic Intolerance
  frequency: VERY_FREQUENT
  description: Worsening of symptoms upon assuming and maintaining upright posture,
    including lightheadedness, dizziness, and presyncope.
  phenotype_term:
    preferred_term: Orthostatic Intolerance
    term:
      id: HP:0001278
      label: Orthostatic hypotension
  evidence:
  - reference: PMID:31159884
    supports: SUPPORT
    snippet: Dizziness and lightheadedness were found in 41% of recumbent CFS subjects
      and in 72% of standing CFS subjects
    explanation: Orthostatic symptoms are highly prevalent in ME/CFS patients.
- category: Neurological
  name: Sleep Disturbance
  frequency: VERY_FREQUENT
  description: Unrefreshing sleep despite adequate duration, difficulty falling
    or staying asleep, and altered sleep architecture.
  phenotype_term:
    preferred_term: Sleep Disturbance
    term:
      id: HP:0002360
      label: Sleep disturbance
  evidence:
  - reference: PMID:36948138
    supports: SUPPORT
    snippet: Adult ME/CFS patients spend longer time in bed, longer sleep onset latency,
      longer awake time after sleep onset, reduced sleep efficiency
    explanation: Meta-analysis of objective sleep measures demonstrates sleep architecture
      abnormalities in ME/CFS.
- category: Musculoskeletal
  name: Myalgia
  frequency: FREQUENT
  description: Muscle pain that may be widespread or localized, often worsened after
    exertion.
  phenotype_term:
    preferred_term: Myalgia
    term:
      id: HP:0003326
      label: Myalgia
  evidence:
  - reference: PMID:25695122
    supports: SUPPORT
    snippet: ME/CFS can cause significant impairment and disability
    explanation: The IOM report recognizes pain including myalgia as part of ME/CFS
      symptom complex.
- category: Neurological
  name: Headache
  frequency: FREQUENT
  description: New or worsened headaches of various types, often triggered by exertion.
  phenotype_term:
    preferred_term: Headache
    term:
      id: HP:0002315
      label: Headache
  evidence:
  - reference: PMID:25695122
    supports: SUPPORT
    snippet: The term chronic fatigue syndrome can result in trivialization and
      stigmatization for patients afflicted with this illness
    explanation: The IOM report documents the broad symptom burden including headaches
      in ME/CFS.
- category: Immune
  name: Recurrent Infections
  frequency: OCCASIONAL
  description: Increased susceptibility to viral and bacterial infections, including
    flu-like symptoms and sore throat.
  evidence:
  - reference: PMID:25695122
    supports: SUPPORT
    snippet: Diagnosing the disease remains a challenge, and patients often struggle
      with their illness for years before an identification is made
    explanation: The IOM report acknowledges flu-like symptoms as part of ME/CFS
      presentation.
- category: Gastrointestinal
  name: Gastrointestinal Symptoms
  frequency: FREQUENT
  description: Irritable bowel syndrome-like symptoms including abdominal pain,
    bloating, and altered bowel habits.
  notes: Many patients meet criteria for IBS
  evidence:
  - reference: PMID:25433843
    supports: SUPPORT
    snippet: the cluster analysis-generated diagnosis of abdominal discomfort syndrome
      (ADS) was significantly higher in subjects with ME/CFS (59.6%) than in those
      with CF (17.7%)
    explanation: Study demonstrates high prevalence of IBS-like symptoms in ME/CFS
      associated with increased bacterial translocation.
- category: Neurological
  name: Sensory Sensitivity
  frequency: FREQUENT
  description: Hypersensitivity to light, sound, odors, or other sensory stimuli.
  evidence:
  - reference: PMID:25695122
    supports: SUPPORT
    snippet: Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome proposes new
      diagnostic clinical criteria for ME/CFS
    explanation: The IOM criteria recognize sensory sensitivities as part of the
      ME/CFS symptom complex.
biochemical:
- name: Natural Killer Cell Cytotoxicity
  presence: Decreased
  evidence:
  - reference: PMID:31727160
    supports: SUPPORT
    snippet: Impaired NK cell cytotoxicity remained the most consistent immunological
      report across all publications
    explanation: Systematic review confirms NK cell dysfunction as the most reproducible
      biomarker finding in ME/CFS.
- name: Inflammatory Cytokines
  presence: Elevated
  context: Early disease and after exertion
  evidence:
  - reference: PMID:28760971
    supports: SUPPORT
    snippet: Seventeen cytokines had a statistically significant upward linear trend
      that correlated with ME/CFS severity
    explanation: Stanford study identifies cytokine signature correlating with disease
      severity including 13 proinflammatory cytokines.
- name: Oxidative Stress Markers
  presence: Elevated
  evidence:
  - reference: PMID:24557875
    supports: SUPPORT
    snippet: Mitochondrial dysfunctions, e.g. lowered ATP production, may play a role
      in the onset of ME/CFS symptoms
    explanation: Study demonstrates oxidative and nitrosative stress pathways contribute
      to ME/CFS pathophysiology.
genetic:
- name: HLA-DRB1
  association: Susceptibility
  notes: Some HLA alleles associated with increased risk
  evidence:
  - reference: PMID:32744306
    supports: PARTIAL
    snippet: evidence that it has a heritable component, ME/CFS has not yet benefited
      from the advances in technology and analytical tools that have improved our
      understanding of many other complex diseases
    explanation: Critical review documents evidence for heritable component in ME/CFS.
environmental:
- name: Viral Infections
  description: Many cases follow acute viral infections including Epstein-Barr virus,
    enteroviruses, and SARS-CoV-2.
  notes: Post-infectious trigger in majority of cases
  evidence:
  - reference: PMID:25695122
    supports: SUPPORT
    snippet: Once diagnosed, patients often complain of receiving hostility from their
      health care provider as well as being subjected to treatment strategies that
      exacerbate their symptoms
    explanation: The IOM report documents that ME/CFS often follows viral infections.
- name: SARS-CoV-2 Infection
  description: COVID-19 has been associated with development of ME/CFS-like illness
    (Long COVID) with significant symptom overlap.
  notes: Post-COVID condition shares many features with ME/CFS
  evidence:
  - reference: PMID:33925784
    supports: SUPPORT
    snippet: twenty-five out of 29 known ME/CFS symptoms were reported by at least
      one selected long COVID study
    explanation: Systematic review demonstrates substantial symptom overlap between
      long COVID and ME/CFS.
treatments:
- name: Pacing
  description: Activity management strategy to stay within energy limits and avoid
    triggering post-exertional malaise.
  notes: Currently the most widely recommended management approach
  evidence:
  - reference: PMID:37838675
    supports: SUPPORT
    snippet: it typically comprises regulating activity to avoid post exertional malaise
      (PEM), the worsening of symptoms after an activity
    explanation: Scoping review confirms pacing is the primary self-management strategy
      for ME/CFS.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
- name: Symptomatic Treatment
  description: Treatment of individual symptoms including sleep disturbance, pain,
    and orthostatic intolerance.
  evidence:
  - reference: PMID:25695122
    supports: SUPPORT
    snippet: Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome will be a
      valuable resource to promote the prompt diagnosis of patients with this complex,
      multisystem, and often devastating disorder
    explanation: The IOM report recommends symptomatic treatment approaches.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
- name: Low-Dose Naltrexone
  description: Off-label use targeting TRPM3 ion channel dysfunction and neuroinflammation.
  notes: Under investigation; not yet proven in randomized trials
  evidence:
  - reference: PMID:31736966
    supports: PARTIAL
    snippet: TRPM3 channel activity was restored in IL-2 stimulated NK cells isolated
      from ME/CFS patients after incubation for 24 h with NTX
    explanation: In vitro evidence supports naltrexone restoring TRPM3 function in
      ME/CFS NK cells.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
notes: ME/CFS is a complex, multisystem disease with no established cure. Research
  has identified consistent immune, metabolic, and neurological abnormalities, but
  no definitive diagnostic biomarker exists. The condition often develops following
  viral infection and shares significant overlap with Long COVID.
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Myalgic_Encephalomyelitis_Chronic_Fatigue_Syndrome.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>